Lilly's triple agonist, retatrutide, delivered weight loss of up to an average of 71.2 lbs
The FDA-approved GLP-1 medications come in injectable pens with precise dosing, whereas compounded GLP-1 drugs typically come in a vial with a syringe that can offer more flexibility for microdosing, but also opens up the chance for taking too much or too little medication
Final Thoughts With Retatrutide now in three formats, vial-size selection comes down to matching material quantity to your real consumption rate
GLP-1 drugs are large, hydrophilic, and charged
Clinical Trial Data: The 3-Month Weight Loss Numbers Dose-by-Dose Breakdown at Week 12 Week-by-Week Weight Loss Timeline Side Effects During the First 3 Months Month 1: What to Expect During the First Four Weeks Month 2: The Peak Challenge Period Month 3: The Relief and Acceleration Phase How Appetite Changes at 3 Months Metabolic Improvements by Week 12 How Retatrutide 3-Month Results Compare to Other Medications Strategies to Maximize Your 3-Month Results Who Responds Best to Retatrutide
3 Cardiac arrhythmias affected 2-11% of participants on retatrutide versus 2% on placebo, but none were serious
.webp)
